You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "GlaxoSmithkline Consumer Healthcare Ltd"

GlaxoSmithkline Consumer Healthcare Ltd Shareholding for the Period Ended June 30 2018

  • 11/07/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Announcement under Regulation 30 (LODR)-Change in Directorate

  • 30/06/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Clarifies on News item

  • 26/06/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Clarification sought from GlaxoSmithkline Consumer Healthcare Ltd

  • 26/06/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Announcement under Regulation 30 (LODR)-Change in Directorate

  • 25/06/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Board Meeting-Closure of Trading Window

  • 06/06/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Fixes Book Closure for Dividend & AGM

  • 12/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

  • 11/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Announcement under Regulation 30 (LODR)-Date of payment of Dividend

  • 11/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Board recommends Dividend (AGM on August 08 2018)

  • 11/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Audited Financial Results For The Year Ended March 31 2018 Intimation Of The Book Closure Dates Date

  • 11/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 09/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Audited Financial Results And Dividend For The Financial Year Ended On March 31 2018.

  • 03/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Board to consider FY18 results & Dividend on May 11 2018

  • 03/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Audited Financial Results And Dividend For The Financial Year Ended On March 31 2018.

  • 03/05/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) R

  • 24/04/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Certificate In Terms Of Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Re

  • 24/04/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Shareholding for the Period Ended March 31 2018

  • 19/04/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Board Meeting-Outcome of Board Meeting

  • 28/03/2018
  • |
  • bse

GlaxoSmithkline Consumer Healthcare Ltd Strategic Review Of Horlicks And Other Consumer Nutrition Products

  • 27/03/2018
  • |
  • bse